Neuregulin 1 and susceptibility to schizophrenia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Human Genetics

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/342734PMID 12145742PMCID PMC378543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2003cited by this paper
• A high-resolution recombination map of the human genome

  2002influential reference
• Localization of a susceptibility gene for common forms of stroke to 5q12.

  2002cited by this paper
• Dopamine receptor functions: lessons from knockout mice [corrected].

  2001cited by this paper
• The N-terminal Region of Neuregulin Isoforms Determines the Accumulation of Cell Surface and Released Neuregulin Ectodomain*

  2001cited by this paper
• Genes, environment and schizophrenia.

  2001cited by this paper
• The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

  2001cited by this paper
• Large upward bias in estimation of locus-specific effects from genomewide scans.

  2001cited by this paper
• Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

  2001cited by this paper
• β-Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons

  2001cited by this paper
• Dopamine receptor functions: lessions from knockout mice

  2001cited by this paper
• Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23.

  2001cited by this paper
• Protection of privacy by third-party encryption in genetic research in Iceland

  2000cited by this paper
• Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

  2000cited by this paper
• Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.

  2000cited by this paper
• The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

  2000cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2000cited by this paper
• Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks.

  2000influential reference
• Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.

  2000cited by this paper
• Erratum to “MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans”

  2000influential reference
• Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.

  2000influential reference
• Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

  1999cited by this paper
• Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat.

  1999influential reference
• Candidate-gene association studies of schizophrenia.

  1999cited by this paper
• Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.

  1999influential reference
• Fluorescence polarization in homogeneous nucleic acid analysis.

  1999cited by this paper
• Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia.

  1999cited by this paper
• Transmission/disequilibrium tests for extended marker haplotypes.

  1999cited by this paper
• Linkage of familial schizophrenia to chromosome 13q32.

  1999influential reference
• Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

  1999cited by this paper
• NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees.

  1998cited by this paper
• Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21

  1998influential reference
• Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail.

  1998cited by this paper
• A genome-wide search for schizophrenia susceptibility genes.

  1998influential reference
• Allele-sharing models: LOD scores and accurate linkage tests.

  1997cited by this paper
• ARIA: a neuromuscular junction neuregulin.

  1997cited by this paper
• ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice.

  1997cited by this paper
• Neuregulin-beta induces expression of an NMDA-receptor subunit.

  1997cited by this paper
• Neuregulin-β induces expression of an NMDA-receptor subunit

  1997cited by this paper
• Parametric and nonparametric linkage analysis: a unified multipoint approach.

  1996cited by this paper
• Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families.

  1996cited by this paper
• Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8.

  1996influential reference
• Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes.

  1995influential reference
• Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

  1995cited by this paper
• Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

  1995influential reference
• Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.

  1995cited by this paper
• Regulation of the acetylcholine receptor epsilon subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation.

  1995cited by this paper
• Differential Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptor Subunits (*)

  1995cited by this paper
• HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes.

  1995cited by this paper
• An E-M algorithm and testing strategy for multiple-locus haplotypes.

  1995cited by this paper
• Syndromes of Schizophrenia

  1994cited by this paper
• Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

  1993influential reference
• Neuropsychology and neurophysiology in schizophrenia

  1993cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• Sensorimotor gating and schizophrenia. Human and animal model studies.

  1990cited by this paper
• Linkage strategies for genetically complex traits. I. Multilocus models.

  1990influential reference
• Research diagnostic criteria: rationale and reliability.

  1978cited by this paper
• Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper

  1977cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper

• Beyond the Wiring: White Matter as a Dynamic Regulator of Brain Function and Disease.

  2026cites this paper
• Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP.

  2026cites this paper
• Depth-Specific Changes in Intracortical Myelin Are Associated with Impaired Executive Function in Chronic Schizophrenia.

  2026cites this paper
• Synergistic SNP-SNP interaction of NRG1 and ERBB4 increases the risk of schizophrenia.

  2025cites this paper
• Cannabis Use and Glutamate across the Psychosis Spectrum: In Vivo Evidence from 7T Proton Magnetic Resonance Spectroscopy

  2025cites this paper
• Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta‐analysis

  2025cites this paper
• PEDIA-BRAIN: A single nuclei multiomic encyclopedia of the human pons provides a resource for normal development and disease vulnerability

  2025cites this paper
• Multiple Roles for Neuregulins and their ERBB Receptors in Neurodegenerative Disease Pathogenesis and Therapy.

  2025cites this paper
• Genetic Predictors of Social and Cognitive Outcomes in People with Ultra-High-Risk of Psychosis Using Spiking Neural Networks

  2025cites this paper
• Common Genomic and Proteomic Alterations Related to Disturbed Neural Oscillatory Activity in Schizophrenia

  2025cites this paper
• Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia.

  2025cites this paper
• Overview of BACE1 structure and effect of genetic polymorphisms and protein isoforms on enzyme activity

  2025cites this paper
• Postnatal critical-period brain plasticity and neurodevelopmental disorders: revisited circuit mechanisms.

  2025cites this paper
• Long non-coding RNAs in schizophrenia.

  2025cites this paper
• Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways

  2024cites this paper
• An emerging role of STriatal-enriched protein tyrosine phosphatase in hyperexcitability-associated brain disorders.

  2024cites this paper
• Systematic discovery of virus-perturbed molecular pathways linking to schizophrenia

  2024cites this paper
• The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis

  2024cites this paper
• Heart rate variability and fasting plasma glucose as trait marker of psychosis: A comparative study between drug naive patients with psychosis and healthy volunteers

  2024cites this paper
• Nrg1 intracellular signaling regulates the development of interhemispheric callosal axons in mice

  2024cites this paper
• Dysregulation of myelination‐related genes in schizophrenia

  2024influential citation
• ErbB inhibition rescues nigral dopamine neuron hyperactivity and repetitive behaviors in a mouse model of fragile X syndrome

  2024cites this paper
• The evolutionary fate of Neanderthal DNA in 30,780 admixed genomes with recent African-like ancestry

  2024cites this paper
• Delineating mechanisms underlying parvalbumin neuron impairment in different neurological and neurodegenerative disorders: the emerging role of mitochondrial dysfunction

  2024cites this paper
• Discovering functional interactions among schizophrenia-risk genes by combining behavioral genetics with cell biology.

  2024cites this paper
• Gene expression changes in Brodmann’s Area 46 differentiate epidermal growth factor and immune system interactions in schizophrenia and mood disorders

  2024cites this paper
• Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer

  2024influential citation
• NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia.

  2024cites this paper
• Correlation of rs35753505 polymorphism in Neuregulin 1 gene with psychopathology and intelligence of people with schizophrenia.

  2023cites this paper
• GluN2D subunit in parvalbumin interneurons regulates prefrontal cortex feed-forward inhibitory circuit and molecular networks relevant to schizophrenia.

  2023cites this paper
• Distinctive effects of NMDA receptor modulators on cerebral microcirculation in a schizophrenia mouse model.

  2023cites this paper
• Genetic labeling reveals spatial and cellular expression pattern of neuregulin 1 in mouse brain

  2023cites this paper
• LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features

  2023cites this paper
• BACE1-dependent metabolism of neuregulin 1: Bridging the gap in explaining the occurrence of schizophrenia-like symptoms in Alzheimer's disease with psychosis?

  2023cites this paper
• Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes

  2023cites this paper
• A Missense Variant in CASKIN1’s Proline-Rich Region Segregates with Psychosis in a Three-Generation Family

  2023cites this paper
• TULP4, a novel E3 ligase gene, participates in neuronal migration as a candidate in schizophrenia.

  2023cites this paper
• Rats, Neuregulins and Radical Prostatectomy: A Conceptual Overview

  2023cites this paper
• The genetic basis of onset age in schizophrenia: evidence and models

  2023cites this paper
• Split-Transformer Impute (STI): Genotype Imputation Using a Transformer-Based Model

  2023cites this paper
• Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System

  2023cites this paper
• The genetics of autism spectrum disorder in an East African familial cohort

  2023cites this paper
• Association of a haplotype in the NRG1 gene with schizophrenia: a case-control study

  2023cites this paper
• Neuregulin-1/PI3K signaling effects on oligodendrocyte proliferation, remyelination and behaviors deficit in a male mouse model of ischemic stroke.

  2023cites this paper
• Genetic predisposition of BDNF (rs6265) gene is susceptible to Schizophrenia: A prospective study and updated meta-analysis.

  2022cites this paper
• Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats

  2022cites this paper
• New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3 , CSMD1 and NRG1 genes

  2022cites this paper
• Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients.

  2022cites this paper
• Repeated Winning and Losing Experiences in Chronic Social Conflicts Are Linked to RNA Editing Pattern Difference

  2022cites this paper
• Effects of psychosis-associated genetic markers on brain volumetry: a systematic review of replicated findings and an independent validation

  2022cites this paper
• Genetic Influences on Cognitive Dysfunction in Schizophrenia.

  2022cites this paper
• Association Analysis of Two Polymorphisms in Neuregulin 1 Gene in a Turkish Schizophrenia Sample

  2022cites this paper
• Toxic and Phenotypic Effects of AAV_Cre Used to Transduce Mesencephalic Dopaminergic Neurons

  2022cites this paper
• Neuregulins: subcellular localization, signaling pathways and their relationship with neuroplasticity and neurological diseases

  2022cites this paper
• ErbB4 in the brain: Focus on high grade glioma

  2022cites this paper
• A Novel Gene Controls a New Structure: PiggyBac Transposable Element-Derived 1, Unique to Mammals, Controls Mammal-Specific Neuronal Paraspeckles

  2022cites this paper
• Screening of ERBB4 SNP rs1026882 in a group of Schizophrenia patients and controls

  2022cites this paper
• Investigation of OLIG2 as a candidate gene for schizophrenia and autism spectrum disorder

  2022cites this paper
• FAM69C, a kinase critical for synaptic function and memory, is defective in neurodegenerative dementia.

  2022cites this paper
• The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia

  2022cites this paper
• What Can We Learn from Animal Models to Study Schizophrenia?

  2022cites this paper
• Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer

  2022cites this paper
• Advantages and Limitations of Animal Schizophrenia Models

  2022cites this paper
• SELENBP1 overexpression in the prefrontal cortex underlies negative symptoms of schizophrenia

  2022cites this paper
• Elevated peripheral Neuregulin-1 protein levels in non-medicated focal epilepsy patients.

  2022cites this paper
• Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors.

  2022cites this paper
• Alterations in prefrontal cortical neuregulin-1 levels in post-pubertal rats with neonatal ventral hippocampal lesions

  2022cites this paper
• Differential expression of miR-148b, miR-129-2 and miR-296 in animal models of schizophrenia-Relevance to NMDA receptor hypofunction.

  2022cites this paper
• Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder.

  2022cites this paper
• Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study

  2022cites this paper
• Adult neural stem cells and schizophrenia

  2022cites this paper
• The molecular genetic basis of creativity: a mini review and perspectives

  2022cites this paper
• The Long Non-Coding RNA GOMAFU in Schizophrenia: Function, Disease Risk, and Beyond

  2022cites this paper
• Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes

  2022cites this paper
• Developmental, neurochemical, and behavioral analyses of ErbB4 Cyt‐1 knockout mice

  2022cites this paper
• Plasticity-Related Gene 5 Is Expressed in a Late Phase of Neurodifferentiation After Neuronal Cell-Fate Determination

  2022cites this paper
• Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model

  2021cites this paper
• Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families

  2021cites this paper
• Early Detection and Prevention of Schizophrenic Psychosis—A Review

  2021cites this paper
• Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition

  2021cites this paper
• Neurobiological substrates of major psychiatry disorders: transdiagnostic associations between white matter abnormalities, neuregulin 1 and clinical manifestation

  2021cites this paper
• Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis

  2021cites this paper
• Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition

  2021influential citation
• Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes

  2021cites this paper
• Novel microRNAs targeting NMDA receptor subunits in animal models of schizophrenia

  2021cites this paper
• The dual hit hypothesis of schizophrenia: evidence from animal models.

  2021cites this paper
• Nrg1 haploinsufficiency alters inhibitory cortical circuits.

  2021cites this paper
• Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research

  2021cites this paper
• PiggyBac Transposable Element-derived 1 controls Neuronal Progenitor Identity, Stress Sensing and mammal-specific paraspeckles

  2021cites this paper
• The laterodorsal tegmentum-ventral tegmental area circuit controls depression-like behaviors by activating ErbB4 in DA neurons

  2021cites this paper
• Dopamine System, NMDA Receptor and EGF Family Expressions in Brain Structures of Bl6 and 129Sv Strains Displaying Different Behavioral Adaptation

  2021cites this paper
• The importance of non-coding RNAs in environmental stress-related developmental brain disorders: a systematic review of evidence associated with exposure to alcohol, anesthetic drugs, nicotine, and viral infections.

  2021cites this paper
• Etiopathogenesis of schizophrenia – the state of the art for 2021

  2021cites this paper
• Disorganization of Oscillatory Activity in Animal Models of Schizophrenia

  2021cites this paper
• Striatal transcriptome changes linked to drug‐induced repetitive behaviors

  2021cites this paper
• Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia.

  2021cites this paper
• Neuregulins in Neurodegenerative Diseases

  2021cites this paper
• Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features.

  2021cites this paper
• An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

  2021cites this paper
• Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation

  2021cites this paper